ARDEX EP 2000 Resin

Hazard statements (CLP)

H315, H317, H319, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Causes serious eye irritation. May cause an allergic skin reaction

Hazard pictograms

GHS07 GHS09

Signal word

Warning

Contains

reaction product: bisphenol-A-(epichlorhydrin), epoxy resin (number average molecular weight ≤ 700); oxirane, mono[(C12-14-alkyloxy)methyl] derivs.

Hazard statements

H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H411 - Toxic to aquatic life with long lasting effects.

Precautionary statements

P102 - Keep out of reach of children. P280 - Wear eye protection, protective gloves. P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention.

Supplemental label elements

EUH205 - Contains epoxy constituents. May produce an allergic reaction.

Additional information

Dispose of contents/container in accordance with regional/national/international/local regulations.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH oxirane, mono[(C12-14-alkyloxy)methyl] derivs. (68609-97-2) regulation, in accordance with Annex XIII Substance(s) not meeting the vPvB criteria of REACH oxirane, mono[(C12-14-alkyloxy)methyl] derivs. (68609-97-2) regulation, in accordance with Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % Component Substance(s) not included in the list established in 2,2-bis-[4(2,3-epoxypropoxy)phenyl]propane (1675-54-3), Bisphenol F diglycidyl ether, accordance with Article 59(1) of REACH for having mixture of isomers (2095-03-6) endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605

2.1 Classification of the substance or mixture

Skin corrosion/irritation, Category 2 H315 Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Chronic Hazard, H411 Category 2 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Causes serious eye irritation. May cause an allergic skin reaction. 2.2. Label elements